Financials

  • Market Capitalization 69.38 M
  • Employee 33
  • Founded 2011
  • CEO N/A
  • Website www.elicio.com
  • Headquarter Delaware, United States
  • FIGI BBG00444GM02
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.84
ratio cours/chiffre d'affaires
5 105.86

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4105
SPRO
Spero Therapeutics, Inc. - Common Stock
1.20 USD-1.64%-2.44%+1.69%-41.18%69.88 M USD
4114
CSBR
Champions Oncology, Inc. - Common Stock
5.00 USD+1.42%+0.40%-4.94%-24.92%69.47 M USD
4116
PLRX
Pliant Therapeutics, Inc. - Common Stock
1.12 USD+1.82%-2.61%+5.66%-30.43%69.35 M USD
4118
TENX
Tenax Therapeutics, Inc. - Common Stock
1.79 USD-2.72%-22.17%-86.99%-76.29%66.99 M USD

Nouvelles